Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Traditional cancer treatment methods, such as chemotherapy and radiotherapy, are undeniably effective in combating cancer. However, they often come with a set of side effects that can significantly impact the well-being of patients. These side effects range from hair loss to a weakened immune system, varying depending on the type and stage of cancer.
In contrast, biological therapies emerge as a promising alternative, offering a way to mitigate the adverse effects associated with conventional treatments. These therapies have proven to be successful, providing comparable success rates in treating cancer patients, especially those in the early stages, with success rates ranging from 27% to 35%.
What sets biological therapies apart is their ability to minimize the intensity of side effects, making the treatment process more tolerable for patients. The reduced impact on the overall health of the individual undergoing treatment contributes to a better quality of life during and after therapy. This characteristic has significantly contributed to the widespread acceptance of biological therapies and has become a driving force behind the growth of this segment in the medical industry.
The surge in cancer diagnoses worldwide demands innovative and advanced treatment options. Cancer, being the second leading cause of death globally according to the World Health Organization (WHO), necessitates a continuous exploration of effective therapies. Notably, lung cancers, including trachea and bronchus cancers, accounted for a staggering 1.6 million deaths in 2012 alone. The alarming prevalence of cancer underscores the urgent need for drugs, treatments, and therapies that can effectively address this global health challenge.
In this landscape, biological therapies have gained considerable popularity and attention. Patients, cancer treatment centers, and research institutes are actively seeking information about these therapies, contributing to a growing awareness and understanding of their benefits. As information dissemination continues, the popularity of biological therapies is expected to rise, further propelling market growth.
The positive response to biological therapies can be attributed to their efficacy in achieving comparable success rates in cancer treatment while minimizing the distressing side effects associated with traditional methods. Patients and healthcare providers are increasingly recognizing the value of biological therapies in providing a more targeted and tailored approach to cancer care.
The growing demand for advanced cancer treatments coupled with the need for options with fewer side effects has positioned biological therapies as a critical player in the global fight against cancer. The acceptance and adoption of these therapies are anticipated to drive market growth, offering a ray of hope for cancer patients seeking effective and less burdensome treatment options.
Carcinoid Syndrome Management Market Highlights:
Carcinoid Syndrome Management Market Overview
Carcinoid Syndrome Management Market Size was valued at USD 1.7 Billion in 2023. The Global Carcinoid Syndrome Management industry is projected to grow from USD 2.1 Billion in 2024 to USD 4.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.65% during the forecast period (2024 - 2032).
Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor. The management or treatment of carcinoid syndrome often requires palliative and supportive care. Management of carcinoid syndrome involves drug therapy or surgical removal of carcinoid tumor from the organ.
Increasing incidence of hormonal disorders, growing smoking habits, levels of carcinogen in highly developed countries etc. are the major driving factor, driving the growth of the market. The only factor restraining the growth of carcinoid syndrome management market is that no availability of drugs approved to manage carcinoid syndrome.
Study objectives:
- To provide detail analysis of parent market and the changing market dynamics of the industry.
- To provide detail analysis of the market structure along with estimated future growth forecast about various segments and sub-segments of the carcinoid syndrome management market.
- To provide in depth market segmentation and historical, current and projected market size in terms of value and volume with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future growth prospect.
- To provide detailed analysis on recent industry trends and developments, strategies of key players and competitive landscape of the Carcinoid Syndrome Management Market.
- To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments currently taking place in the Carcinoid Syndrome Management Market.
Figure 1 Carcinoid Syndrome Management Market by Organs Affected 
Key Players of Carcinoid Syndrome Management Market
Key players profiled in the Carcinoid Syndrome Management Market are
- Novartis International AG (Sandoz) (Switzerland)
- Pharmascience Inc. (Canada)
- Omega Laboratories Ltd. (Canada)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Mylan N.V. (USA)
- Ipsen Biopharmaceuticals, Inc.(US)
- Sirtex Medical Limited (Australia)
- BTG International Ltd. (UK)
- Wockhardt Ltd.
- Sun Pharmaceutical Industries Limited (India)
Carcinoid Syndrome Management Market Segmentation
The carcinoid syndrome management market is segmented on the basis of organs affected by the disease, treatment procedures and end users. Based on organs affected by the disease, the market has been segmented into small intestine, lungs, rectum, appendix, colon, stomach, pancreas, liver and others. Based on treatment type, the market has been segmented into chemotherapy, biological therapy, and hepatic artery embolization agents. Further on the basis of end users the market has been segmented as hospital, clinics, and cancer institute and treatment centers.
The report for Carcinoid Syndrome Management by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Intended Audience
- Global carcinoid syndrome management or treatment device manufacturers & suppliers
- Contract research organizations (CROs)
- Research and development (R&D) companies
- Government research laboratories
- Independent research laboratories
- Government and independent regulatory authorities
- Market research and consulting service providers
- Academic institutes and universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
